0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

LOCAL AND SYSTEMIC EFFECTS FROM INHALATION OF STRONG SOLUTIONS OF EPINEPHRINE

J. V. GALGIANI, M.D.; FREDERICK PROESCHER, M.D.; WILLIAM DOCK, M.D.; M. L. TAINTER, M.D.
JAMA. 1939;112(19):1929-1933. doi:10.1001/jama.1939.02800190043011.
Text Size: A A A
Published online

Inhalation of vaporized 1 per cent solution of epinephrine is extensively used in the relief of bronchial asthma.1 This is a convenient way of obtaining directly the well known bronchodilator action of epinephrine without the necessity of hypodermic injection. The clinical results have been generally good as to relief of asthmatic attacks. At least ten atomizers are advertized as specially designed for this purpose, and, in addition, 1 per cent solution of epinephrine is the active ingredient of a large number of trade-marked anti-asthma products offered to the public. In spite of the widespread use of this strong concentration of epinephrine, no reports have been made as to possible local irritative effects on the respiratory tract. When it is remembered that deep inhalations of this potent drug are practiced almost indefinitely in a chronic disease state, it would appear desirable to understand more fully and definitely, if possible, the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();